Adial Pharmaceuticals, Inc.
ADIL
$0.2454
$0.00642.68%
NASDAQ
| 03/31/2025 | 12/31/2024 | ||||
|---|---|---|---|---|---|
| Revenue | -- | -- | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -- | -- | |||
| Cost of Revenue | -- | -- | |||
| Gross Profit | -- | -- | |||
| SG&A Expenses | 25.66% | 2.55% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 16.83% | -12.25% | |||
| Operating Income | -16.83% | 12.25% | |||
| Income Before Tax | -7.63% | 5.52% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | -7.63% | 5.52% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | -7.63% | 5.52% | |||
| EBIT | -16.83% | 12.25% | |||
| EBITDA | -16.83% | 12.24% | |||
| EPS Basic | -5.58% | 14.06% | |||
| Normalized Basic EPS | 68.67% | -193.82% | |||
| EPS Diluted | -5.58% | 14.06% | |||
| Normalized Diluted EPS | 68.67% | -193.82% | |||
| Average Basic Shares Outstanding | 1.94% | 9.94% | |||
| Average Diluted Shares Outstanding | 1.94% | 9.94% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||